Pancreatic Cancer Research

ResearcherGuiyang Medical UniversityActive in the last 2 years

Xiaobin Fei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9869-9184; OpenAlex author ID A5028747359. Sources: OpenAlex.

Their work

Papers
10
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2023: 4 papers · 2024: 4 papers · 2025: 1 paper · 2026: 1 paper

Papers 10

  1. UBE3A-mediated mH2A1 Ubiquitination activates TERT transcription to promote senescence resistance in pancreatic cancer. Co-author DOI 10.1038/s41419-026-08480-z↗
  2. PSMD14-Mediated LDHA Deubiquitination Upregulates ACLY Expression via H3K18 Lactylation to Promote Lipid Synthesis and Pancreatic Cancer Progression. Co-author DOI 10.1002/advs.202505762↗
  3. Unveiling the role of PYGB in pancreatic cancer: a novel diagnostic biomarker and gene therapy target. Co-author DOI 10.1007/s00432-024-05644-2↗
  4. TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, invasion, and metastasis of pancreatic canc… Co-author DOI 10.1016/j.cellsig.2024.111227↗
  5. PELI1: key players in the oncogenic characteristics of pancreatic Cancer. Co-author DOI 10.1186/s13046-024-03008-9↗
  6. A study on the role of Taxifolin in inducing apoptosis of pancreatic cancer cells: screening results using weighted gene co-expression network analysis. Co-author DOI 10.18632/aging.205500↗
  7. FBXO28 promotes proliferation, invasion, and metastasis of pancreatic cancer cells through regulation of SMARCC2 ubiquitination. Co-author DOI 10.18632/aging.204780↗
  8. Correction for: FBXO28 promotes proliferation, invasion, and metastasis of pancreatic cancer cells through regulation of SMARCC2 ubiquitination. Co-author DOI 10.18632/aging.205071↗
  9. The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR sig… Co-author DOI 10.3389/fonc.2023.1169833↗
  10. Analysis and validation of the potential of the MYO1E gene in pancreatic adenocarcinoma based on a bioinformatics approach. Co-author DOI 10.3892/ol.2023.13871↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yaozhen Pan · 8 shared papers, 2023–2024 · strength 1.62
  2. Likun Ren · 5 shared papers, 2024–2026 · strength 1.18
  3. Songbai Liu · 6 shared papers, 2023–2024 · strength 1.15
  4. Shaojie Chen · 3 shared papers, 2024–2026 · strength 0.76
  5. Yongjia Gao · 3 shared papers, 2024–2025 · strength 0.65
  6. Peng Liu · 3 shared papers, 2023–2024 · strength 0.61
  7. Rishang Lu · 2 shared papers, 2025–2026 · strength 0.53
  8. Yaozhen Pan · 2 shared papers, 2025–2026 · strength 0.53
  9. Peng Liu · 2 shared papers, 2023–2025 · strength 0.42
  10. Xing Wang · 2 shared papers, 2024 · strength 0.42
  11. Zhiwei He · 2 shared papers, 2023 · strength 0.34
  12. Xing Wang · 1 shared paper, 2025 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.